농업용 항균제 : 시장 점유율 분석, 산업 동향, 통계, 성장 예측(2025-2030년)

The agricultural antibacterials market size is valued at USD 11.70 billion in 2025 and is projected to reach USD 14.70 billion by 2030, registering a CAGR of 4.70%.

The market expansion is attributed to intensifying climate-related bacterial disease pressure, increased protected-crop cultivation, and technological advancements in nano-copper and biological bactericides. Although copper-based products maintain market dominance, regulatory requirements and retailer sustainability mandates are accelerating the adoption of host-specific biological solutions and precision application systems. The Asia-Pacific region remains the primary demand center, while North America and Europe establish regulatory frameworks and technological standards that will influence market development through 2030. Key suppliers are strategically diversifying their portfolios toward biological and digital solutions, generating market opportunities through IoT-enabled application timing, bacteriophage commercialization, and nano-dispersion formulations that deliver optimal efficacy at reduced application rates.

Global Agricultural Antibacterials Market Trends and Insights

Surging Food-Supply Pressure

Global food security requirements necessitate a 50% increase in food production by 2050, while bacterial pathogens currently generate annual crop losses exceeding USD 60 billion. Agricultural producers in the Asia-Pacific region implement systematic antibacterial programs, with China maintaining pesticide consumption at 240,000-250,000 metric tons annually through 2025, including over 90,000 metric tons of biologicals. Export-oriented fruit and vegetable producers comply with stringent zero-tolerance residue requirements, sustaining demand for premium antibacterial solutions that ensure optimal crop yields and market accessibility.

Expansion of Protected-Crop Acreage

Greenhouse and tunnel operations in North America and Europe experience 8-12% annual growth, resulting in dense plant canopies with temperature-humidity profiles conducive to bacterial growth.Tomato and cucumber facilities in the Netherlands and Canada report 20% higher antibacterial application frequencies compared to open-field operations. This increase drives demand for water-system compatible formulations. In response, suppliers focus on developing nano-dispersions and low-phytotoxic formulations to protect recirculating hydroponic nutrient streams.

Escalating Antibiotic Resistance in Plant-Pathogenic Bacteria

Erwinia amylovora and Xanthomonas strains develop resistance to streptomycin treatments within five to seven seasons. The resistance issue is particularly severe in perennial crops such as apples and citrus, where bacterial populations persist across growing seasons and accumulate resistance genes through horizontal transfer. Orchards face 25-40% higher input costs as growers must rotate multiple active ingredients and implement costly monitoring systems. While phage blends and copper-zinc hybrids offer alternative solutions, their adoption requires operator training and specialized spray equipment.

Other drivers and restraints analyzed in the detailed report include:

1. Climate-Linked Rise in Bacterial Incidence
2. Rapid Uptake of Digital Disease Forecast and IoT Sensor
3. Tightening Regulatory Requirements Create Registration Risk for New Antibiotics

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Copper compounds generated 61% of 2024 revenue in the agricultural antibacterial market, demonstrating the continued reliance on established multi-site chemistry. Nano-copper dispersions and hybrid Cu/Zn blends are experiencing growth at a 13.6% CAGR, driven by agricultural demands for reduced dosage and residue levels. While biologicals represent a smaller market share, they account for 74% of the biopesticide segment and maintain strong growth rates. The European Union's planned copper phase-out in 2025 presents a significant risk to the dominant copper segment and may accelerate the transition to bacteriophages and synthetic peptides.

The multi-site approach remains effective as bacterial resistance requires multiple simultaneous mutations. However, environmental accumulation concerns and retail policies challenge its future sustainability. Dithiocarbamates and amides serve specific applications where copper causes plant toxicity, while traditional antibiotics decline due to antimicrobial resistance policies. Investment flows toward nano-enabled delivery systems that achieve comparable field performance with 40-60% less metallic content, serving as transitional solutions until biological alternatives reach full commercial development.

Multi-site cell-wall disruptors maintain a dominant 43% share of the 2024 agricultural antibacterials market. Oxidative-stress inducers, enhanced by nano-particle carrier systems, demonstrate an 11.1% annual growth rate, supported by trial data showing improved lesion control and reduced phytotoxicity. Protein-synthesis inhibitors face regulatory restrictions due to resistance development and concerns over shared mechanisms with human health applications, particularly in orchard use. DNA/RNA blockers command higher prices in greenhouse ornamental applications where systemic activity meets aesthetic requirements, though limited approved uses restrict broader agricultural adoption.

The distribution of mechanisms reflects a market shift toward broad-spectrum chemistries that combat resistance while meeting environmental requirements, avoiding lengthy registration processes associated with new single-target antibiotics. Companies are integrating traditional copper-based products with oxidative nano-formulations and biological products to provide comprehensive disease control across multiple crop types.

The Agricultural Antibacterials Market is Segmented by Product Type (Copper-Based, and More), Mode of Action (Protein-Synthesis Inhibitors and More), Formulation Form (Liquid Suspensions and More), Application Method (Foliar Spray and More), Crop Type (Cereals and Grains, and More), Distribution Channel (Manufacturer Direct and More), and Geography (North America and More). The Market Forecasts are Provided in Terms of Value (USD).

Geography Analysis

Asia-Pacific holds 33% of the agricultural antibacterials market share in 2024 and is projected to grow at an 8.2% CAGR through 2030. China maintains its total pesticide consumption at 250,000 metric tons, with biologicals accounting for 90,000 metric tons due to green-development policies. India's agrochemical market is boosting, with government initiatives targeting 26 million hectares for organic farming. The region's tropical humidity creates persistent bacterial blight in rice and citrus canker, necessitating year-round application programs. Japan and Australia focus on high-value fresh produce exports, implementing nano-copper dispersions to comply with international residue requirements.

North America maintains a mature market with technological advancement. The United States and Canada show steady growth in protected cultivation, increasing the need for drip-injected antibacterials in recirculating systems. EPA evaluations of agricultural antibiotics create market uncertainty while driving development in phage-based alternatives and digital support systems. Mexico continues to expand its vegetable exports, maintaining high bactericide usage to comply with United States import regulations.

Europe faces regulatory challenges with the European Green Deal mandating a 50% reduction in chemical pesticides by 2030. The 2025 copper regulation expiration drives growers toward microbial alternatives, while research focuses on synthetic peptides and RNA-based bactericides. Germany, France, and Spain lead biological adoption, while Central and Eastern European producers evaluate nano-copper solutions to maintain efficacy during transition periods. The United Kingdom maintains EU regulatory alignment while developing streamlined approvals for new biologicals to balance environmental protection with crop security. Russia increases grain production area, requiring efficient copper formulations, though Western supplier access remains limited by geopolitical factors.

1. Bayer AG
2. Syngenta AG
3. Corteva Agriscience
4. Nufarm
5. Sumitomo Chemical Co., Ltd.
6. AMVAC Chemical Corporation
7. UPL
8. Albaugh LLC
9. Gowan Company, L.L.C.
10. Certis Biologicals (A Subsidiary of Mitsui & Co., Ltd.)
11. Koppert
12. BioWorks Inc. (Biobest)
13. BioSafe Systems, LLC
14. Phagelux AgriHealth, Inc
15. Parijat Industries (India) Pvt. Ltd.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Surging Food-Supply Pressure
  • 4.2.2 Expansion of Protected-Crop Acreage
  • 4.2.3 Climate-Linked Rise in Bacterial Incidence
  • 4.2.4 Rapid Uptake of Digital Disease Forecast and IoT Sensor
  • 4.2.5 Commercialisation of Bacteriophage-Based Products
  • 4.2.6 Growth of Recirculating Soilless Systems
• 4.3 Market Restraints
  • 4.3.1 Escalating Antibiotic Resistance in Plant-Pathogenic Bacteria
  • 4.3.2 Tightening Regulatory Requirements Creates Registration Risk for New Antibiotics
  • 4.3.3 Short Shelf Life and Cold-Chain Requirements for Biological Bactericides
  • 4.3.4 ESG and Retailer De-listing of Heavy-Metal Bactericides
• 4.4 Regulatory Landscape
• 4.5 Technological Outlook
• 4.6 Porter's Five Forces Analysis
  • 4.6.1 Bargaining Power of Suppliers
  • 4.6.2 Bargaining Power of Buyers
  • 4.6.3 Threat of New Entrants
  • 4.6.4 Threat of Substitutes
  • 4.6.5 Intensity of Competitive Rivalry

5 Market Size and Growth Forecasts (Value, USD)

• 5.1 By Product Type
  • 5.1.1 Copper-Based
  • 5.1.2 Dithiocarbamates
  • 5.1.3 Amides
  • 5.1.4 Nano Copper and Hybrid Cu/Zn
  • 5.1.5 Antibiotics
  • 5.1.6 Biologicals
  • 5.1.7 Other Synthetic Types
• 5.2 By Mode of Action
  • 5.2.1 Multi-site Cell-wall Disruptors
  • 5.2.2 Protein-Synthesis Inhibitors
  • 5.2.3 Oxidative Stress Inducers
  • 5.2.4 DNA/RNA Synthesis Blockers
• 5.3 By Formulation Form
  • 5.3.1 Liquid Suspensions
  • 5.3.2 Liquid-Dispersible Granules (WDG)
  • 5.3.3 Wettable Powders
  • 5.3.4 Nano-dispersions and Encapsulates
• 5.4 By Application Method
  • 5.4.1 Foliar Spray
  • 5.4.2 Seed/Transplant Treatment
  • 5.4.3 Soil Injection
  • 5.4.4 Water-System and Drip-Irrigation Injection
• 5.5 By Crop Type
  • 5.5.1 Cereals and Grains
  • 5.5.2 Oilseeds and Pulses
  • 5.5.3 Fruits and Vegetables
  • 5.5.4 Commercial Cash Crops
  • 5.5.5 Greenhouse Crops
  • 5.5.6 Turf and Ornamentals
• 5.6 By Distribution Channel
  • 5.6.1 Manufacturer Direct
  • 5.6.2 Ag-Retail/Co-ops
  • 5.6.3 Online and E-commerce Platforms
• 5.7 By Geography
  • 5.7.1 North America
    • 5.7.1.1 United States
    • 5.7.1.2 Canada
    • 5.7.1.3 Mexico
    • 5.7.1.4 Rest of North America
  • 5.7.2 Europe
    • 5.7.2.1 Germany
    • 5.7.2.2 United Kingdom
    • 5.7.2.3 France
    • 5.7.2.4 Spain
    • 5.7.2.5 Russia
    • 5.7.2.6 Rest of Europe
  • 5.7.3 Asia-Pacific
    • 5.7.3.1 China
    • 5.7.3.2 India
    • 5.7.3.3 Japan
    • 5.7.3.4 Australia
    • 5.7.3.5 New Zealand
    • 5.7.3.6 Rest of Asia-Pacific
  • 5.7.4 South America
    • 5.7.4.1 Brazil
    • 5.7.4.2 Argentina
    • 5.7.4.3 Rest of South America
  • 5.7.5 Middle East
    • 5.7.5.1 United Arab Emirates
    • 5.7.5.2 Saudi Arabia
    • 5.7.5.3 Turkey
    • 5.7.5.4 Rest of Middle East
  • 5.7.6 Africa
    • 5.7.6.1 South Africa
    • 5.7.6.2 Rest of Africa

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Strategic Moves
• 6.3 Market Share Analysis
• 6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
  • 6.4.1 Bayer AG
  • 6.4.2 Syngenta AG
  • 6.4.3 Corteva Agriscience
  • 6.4.4 Nufarm
  • 6.4.5 Sumitomo Chemical Co., Ltd.
  • 6.4.6 AMVAC Chemical Corporation
  • 6.4.7 UPL
  • 6.4.8 Albaugh LLC
  • 6.4.9 Gowan Company, L.L.C.
  • 6.4.10 Certis Biologicals (A Subsidiary of Mitsui & Co., Ltd.)
  • 6.4.11 Koppert
  • 6.4.12 BioWorks Inc. (Biobest)
  • 6.4.13 BioSafe Systems, LLC
  • 6.4.14 Phagelux AgriHealth, Inc
  • 6.4.15 Parijat Industries (India) Pvt. Ltd.

7 Market Opportunities and Future Outlook